Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities (2023) Erlmeier F, Sun N, Shen J, Feuchtinger A, Buck A, Prade VM, Kunzke T, et al. Journal article Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma (2022) Mikuteit M, Zschäbitz S, Erlmeier M, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F Journal article Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma (2022) Mikuteit M, Steffens S, Zschäbitz S, Autenrieth M, Weichert W, Hartmann A, Erlmeier F Journal article A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) Wein A, Stöhr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, et al. Journal article Digital Follow-Up and the Perspective of Patient-Centered Care in Oncology: What's the PROblem? (2020) Giordano FA, Welzel G, Siefert V, Jahnke L, Ganslandt T, Wenz F, Grosu AL, et al. Journal article, Review article Palliative Treatment of Colorectal Cancer with Secondary Metastasis Resection in Germany - Impact of the Multidisciplinary Treatment Approach on Prognosis and Cost: The Northern Bavaria IVOPAK I Project (2015) Wein A, Emmert M, Merkel S, Harich HD, Thiemann R, Lamberti C, Göttler B, et al. Journal article, Medical case study Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09) (2015) Niegisch G, Retz M, Thalgott M, Balabanov S, Honecker F, Ohlmann CH, Stoeckle M, et al. Journal article Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer (2014) Maass N, Schem C, Bauerschlag DO, Tiemann K, Schaefer FW, Hanson S, Muth M, et al. Journal article Nilotinib in combination with carboplatin and paclitaxel is a candidate for ovarian cancer treatment (2014) Weigel MT, Rath K, Alkatout I, Wenners AS, Schem C, Maass N, Jonat W, Mundhenke C Journal article